Looks like you clickedhttps://news.abbvie.com/news/imbruvica-ibrutinib-data-in-chronic-lymphocytic-leukemia-cll-show-up-to-seven-years-progression-free-survival-pfs-in-80-percent-previously-untreated-patients-longest-follow-up-for-brutons-tyrosine-kinase-inhibitor-to-date.htm
If you do not want to visit that page, you can close this browser tab.
